Results 21 to 30 of about 40,585 (248)

Delirium due to Anticholinergic Intoxication and Use of Physostigmine in Pediatric Emergency Room

open access: yes, 2022
Anticholinergics are substances that antagonize the activity of the neurotransmitter acetylcholine. Anticholinergic syndrome (AS) occurs following a suicidal overdose, accidental drug intake, drug incompatibilities, and intake of multiple drugs ...
Alper Çiçek   +7 more
core   +1 more source

Management of cognitive and negative symptoms in schizophrenia [PDF]

open access: yesMental Health Clinician, 2022
Currently available antipsychotics provide only modest benefit in managing the cognitive and negative symptoms of schizophrenia even though these symptoms are often the most impairing in patients daily lives.
Megan Maroney, PharmD, BCPP
doaj   +1 more source

Sex Differences in Prescribing Patterns of Anticholinergics and β3-Adrenoceptor Agonists for Overactive Bladder: A Nationwide Study in Japan, FY2017-FY2024. [PDF]

open access: yesLow Urin Tract Symptoms
ABSTRACT Objectives Drug treatment for overactive bladder (OAB) is changing, with an increasing share of β3‐adrenoceptor agonists relative to anticholinergics, but it is not known how far this change has progressed in older people, who are most vulnerable to the risks of anticholinergics.
Koike T   +9 more
europepmc   +2 more sources

Anticholinergic load in patients older 65 years with ambulatory pharmacological treatment in a Colombian population

open access: yesIatreia, 2019
Background: Drugs with potential anticholinergic effect are usually prescribed to the population over 65 years. There are several scales created to calculate anticholinergic burden: Anticholinergic Drug Scale, Anticholinergic Risk Scale, and ...
Vallejos Narváez, Álvaro Guillermo   +3 more
doaj   +1 more source

Convergence excess consecutive esotropia associated with 0.01% atropine eye drops usage in patients operated for intermittent exotropia

open access: yesIndian Journal of Ophthalmology, 2020
To report convergence excess esotropia (CEET) following 0.01% atropine eye drops (Low dose atropine [LDA]). Children who developed CEET that resolved promptly after discontinuation of LDA are described.
Mihir Kothari   +5 more
doaj   +1 more source

Anticholinergic Medication and Caries Status Predict Xerostomia under 65

open access: yesDentistry Journal, 2023
The use of anticholinergic medications is increasing in younger ages, yet information about xerostomia, the most common anticholinergic side effect, is limited.
Hui Ling Cheah   +4 more
doaj   +1 more source

Results of medications and bladder managements of vesicoureteral reflux in patients with a spinal cord lesion [PDF]

open access: yesSongklanakarin Journal of Science and Technology (SJST), 2020
The purpose of the present study was to study the outcome of medical treatments and methods used to treat vesicoureteral reflux (VUR) in patients with spinal cord lesions.
Nalinee Tipsri   +3 more
doaj   +1 more source

Anticholinergic burden risk and prevalence of medications carrying anticholinergic properties in elderly cancer patients in Jordan

open access: yes, 2023
Background: Geriatric cancer patients are susceptible to adverse drug events due to the complexity of their chemotherapy regimens and collateral treatments for their comorbid conditions. Prescribing medications with anticholinergic burden characteristics
Ahmad Al-Azayzih   +5 more
core   +1 more source

A Retrospective Database Analysis of Anticholinergic Burden Among Older Patients With and Without Overactive Bladder in South Korea [PDF]

open access: yesInternational Neurourology Journal
Purpose This study aimed to measure the cumulative anticholinergic burden in older outpatients in South Korea with and without newly started overactive bladder (OAB) medications, and to assess the contribution OAB treatment-related antimuscarinics have ...
Kyu-Sung Lee   +7 more
doaj   +1 more source

Efficacy and safety of once-daily aclidinium in chronic obstructive pulmonary disease

open access: yesRespiratory Research, 2011
Background The long-term efficacy and safety of aclidinium bromide, a novel, long-acting muscarinic antagonist, were investigated in patients with moderate to severe chronic obstructive pulmonary disease (COPD).
Bateman Eric D   +11 more
doaj   +1 more source

Home - About - Disclaimer - Privacy